Statistics
Publications
5
Citations
741
H-Index
5
Active since
2014
Philipp Welschof is an author at Johannes Gutenberg University Mainz specializing in medicine, pharmacology, and oxidative stress.
Publications per year
2014–2017
5
5
The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
Sebastian Steven, Matthias Oelze, Alina Hanf et al. · Redox Biology · 2017 · 295 citations · Full text
Matthias Oelze, Swenja Kröller‐Schön, Philipp Welschof et al. · PLoS ONE · 2014 · 287 citations · Full text
Sebastian Steven, Michael Hausding, Swenja Kröller‐Schön et al. · Basic Research in Cardiology · 2015 · 112 citations
Inflammation, Vascular Inflammation/dysfunction, Anti-inflammatory +9
Rows per page
1–5 of 5